Quantinno Capital Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4M Buy
382,571
+41,417
+12% +$1.81M 0.03% 653
2025
Q4
$13.2M Sell
341,154
-53,962
-14% -$2.06M 0.03% 684
2025
Q3
$13.9M Buy
395,116
+186,232
+89% +$6.74M 0.04% 527
2025
Q2
$7.53M Buy
208,884
+88,096
+73% +$2.92M 0.03% 650
2025
Q1
$3.76M Buy
120,788
+47,408
+65% +$1.5M 0.02% 770
2024
Q4
$1.87M Buy
73,380
+16,945
+30% +$449K 0.02% 873
2024
Q3
$1.6M Buy
56,435
+16,982
+43% +$470K 0.02% 810
2024
Q2
$1.04M Sell
39,453
-6,001
-13% -$166K 0.02% 791
2024
Q1
$1.38M Buy
45,454
+15,672
+53% +$462K 0.03% 648
2023
Q4
$837K Buy
29,782
+21,667
+267% +$595K 0.03% 668
2023
Q3
$220K Buy
+8,115
New +$241K 0.01% 957
2023
Q2
Sell
-7,401
Closed -$267K 944
2023
Q1
$267K Buy
+7,401
New +$274K 0.02% 748

Other funds holding RPRX